These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20065640)

  • 1. Antibodies to watch in 2010.
    Reichert JM
    MAbs; 2010; 2(1):84-100. PubMed ID: 20065640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-based therapeutics to watch in 2011.
    Reichert JM
    MAbs; 2011; 3(1):76-99. PubMed ID: 21051951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to watch in 2019.
    Kaplon H; Reichert JM
    MAbs; 2019; 11(2):219-238. PubMed ID: 30516432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies as therapeutics in oncology.
    Trikha M; Yan L; Nakada MT
    Curr Opin Biotechnol; 2002 Dec; 13(6):609-14. PubMed ID: 12482522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology and therapeutic applications of monoclonal antibodies.
    Castelli MS; McGonigle P; Hornby PJ
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00535. PubMed ID: 31859459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New monoclonal antibodies in renal transplantation.
    Vincenti F
    Minerva Urol Nefrol; 2003 Mar; 55(1):57-66. PubMed ID: 12773967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond ipilimumab: new approaches target the immunological synapse.
    Garber K
    J Natl Cancer Inst; 2011 Jul; 103(14):1079-82. PubMed ID: 21737695
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-reactivity of monoclonal antibodies to defined human leucocyte differentiation antigens with bovine cells.
    Sopp P; Howard CJ
    Vet Immunol Immunopathol; 1997 May; 56(1-2):11-25. PubMed ID: 9220577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The developing trend of monoclonal antibodies in the treatment of colorectal cancer.
    Elfiky AA; Saif MW
    Expert Opin Biol Ther; 2007 Jun; 7(6):871-83. PubMed ID: 17555372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Antibodies: A Review.
    Singh S; Kumar NK; Dwiwedi P; Charan J; Kaur R; Sidhu P; Chugh VK
    Curr Clin Pharmacol; 2018; 13(2):85-99. PubMed ID: 28799485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies as innovative therapeutics.
    Reichert JM
    Curr Pharm Biotechnol; 2008 Dec; 9(6):423-30. PubMed ID: 19075682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which are the antibodies to watch in 2013?
    Reichert JM
    MAbs; 2013; 5(1):1-4. PubMed ID: 23254906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future directions in tumor immunotherapy: CTLA4 blockade.
    Gulley JL; Dahut WL
    Nat Clin Pract Oncol; 2007 Mar; 4(3):136-7. PubMed ID: 17327854
    [No Abstract]   [Full Text] [Related]  

  • 14. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal Antibodies in Oncology: A Decade of Novel Options.
    Kardile V; Kulkarni A; Nadar B; Saldanha T
    Cell Biochem Biophys; 2023 Sep; 81(3):395-408. PubMed ID: 37395856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoengineered antibodies: towards the next-generation of immunotherapeutics.
    Mastrangeli R; Palinsky W; Bierau H
    Glycobiology; 2019 Mar; 29(3):199-210. PubMed ID: 30289453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development trends for human monoclonal antibody therapeutics.
    Nelson AL; Dhimolea E; Reichert JM
    Nat Rev Drug Discov; 2010 Oct; 9(10):767-74. PubMed ID: 20811384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies in oncology.
    Pillay V; Gan HK; Scott AM
    N Biotechnol; 2011 Sep; 28(5):518-29. PubMed ID: 21473941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycans as targets for therapeutic antitumor antibodies.
    Rabu C; McIntosh R; Jurasova Z; Durrant L
    Future Oncol; 2012 Aug; 8(8):943-60. PubMed ID: 22894669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.